Cardinal Health, Inc. $CAH Shares Bought by Engineers Gate Manager LP

Engineers Gate Manager LP lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 59.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 90,979 shares of the company’s stock after purchasing an additional 33,743 shares during the quarter. Engineers Gate Manager LP’s holdings in Cardinal Health were worth $18,696,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Nordea Investment Management AB grew its holdings in Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after acquiring an additional 494,731 shares during the period. Victory Capital Management Inc. boosted its position in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after purchasing an additional 707,495 shares in the last quarter. Procyon Advisors LLC grew its stake in shares of Cardinal Health by 78.7% in the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after purchasing an additional 7,499 shares during the last quarter. Public Sector Pension Investment Board raised its holdings in shares of Cardinal Health by 66.7% in the 3rd quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock worth $4,710,000 after purchasing an additional 12,003 shares in the last quarter. Finally, Sierra Summit Advisors LLC acquired a new stake in Cardinal Health during the third quarter valued at approximately $9,897,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Down 0.6%

Shares of NYSE:CAH opened at $226.29 on Thursday. The company’s fifty day moving average is $204.01 and its two-hundred day moving average is $209.11. The company has a market cap of $53.00 billion, a P/E ratio of 34.60, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter last year, the firm posted $2.35 earnings per share. Cardinal Health’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Evercore decreased their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. William Blair started coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. TD Cowen upped their target price on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a report on Friday, May 1st. Barclays increased their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Finally, Leerink Partners restated an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a report on Monday, March 9th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.